checkAd

     101  0 Kommentare Taro Annual Report on Form 20-F Available For Fiscal Year Ended March 31, 2022

    Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro”) announced that its Annual Report on Form 20-F for the fiscal year ended March 31, 2022, filed with the Securities and Exchange Commission (the “SEC”), is available within the Investor Relations section of Taro’s website at www.taro.com.

    Hard copies of the report may be ordered free of charge by sending requests to:

    Taro Pharmaceuticals U.S.A., Inc.
    3 Skyline Drive
    Hawthorne, NY 10532
    Attn.: William J. Coote or
    via email to William.Coote@taro.com

    Additionally, the report may be accessed on the SEC’s website at www.sec.gov.

    ****

    Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit Taro’s website at www.taro.com.

    Lesen Sie auch




    Business Wire (engl.)
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors


    Verfasst von Business Wire (engl.)
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Taro Annual Report on Form 20-F Available For Fiscal Year Ended March 31, 2022 Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro”) announced that its Annual Report on Form 20-F for the fiscal year ended March 31, 2022, filed with the Securities and Exchange Commission (the “SEC”), is available within the Investor …